Transparency Market Research has published a new report on the global biotherapeutics cell line development market. As per the report, the global biotherapeutics cell line development market is expected to expand at a 7.50% CAGR from 2015 to 2022. The report, titled ‘Biotherapeutics Cell Line Development Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022,’ states that the global biotherapeutics cell line development market is expected to progress from US$56 mn in 2014 to US$99.8 mn by 2022 owing to factors such as the rising demand for monoclonal antibodies and the rising initiatives taken by the governments of various nations to fund life sciences research and development.
Browse the full Biotherapeutics Cell Line Development Market (by Process, CLD Option and by Geography): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2022 report at https://www.transparencymarketresearch.com/biotherapeutics-cell-line-development-market.html?
The biotherapeutics industry continues to grow swiftly owing to the growing demand for mammalian cell line development. Over the past few years, big pharmaceutical companies have been pursuing the development of small molecule drugs by aggressively investing in biotechnology. The increasing occurrence of various diseases has led to an increase in the demand for biotherapeutics. The rising aging population is expected to propel the global biotherapeutics cell line development market in the next few years. As per the data presented by the International Diabetes Federation (2014), the percentage of the population suffering from diabetes is expected to increase to 53% during the period from 2014 to 2035.
The global biotherapeutics cell line development market is segmented on the basis of geography, process, and cell line development option. Based on process, the global biotherapeutics cell line development market is classified into single cell cloning and transfection. The single cell cloning segment is sub-segmented by method into manual limited dilution cloning, ClonePix, FACS, and others. In 2014, the global biotherapeutics cell line development market was led by the manual limited dilution cloning segment, which accounted for 37.4%.
Based on geography, the global biotherapeutics cell line development market is divided into Europe, the Middle East and Africa, Latin America, Asia Pacific, and North America. In 2014, the global biotherapeutics cell line development market was dominated by North America, followed by Europe. The increasing demand for biotherapeutics cell line development due to the rising aging population is expected to propel the North America biotherapeutics cell line development market in the years to come. In 2014, Asia Pacific was the third largest market in the global biotherapeutics cell line development market. It is expected that the Asia Pacific biotherapeutics cell line development market will grow at the highest CAGR through the forecast period.
Some of the prominent players operating in the global biotherapeutics cell line development market are Becton Dickinson & Company (U.S.), Boehringer Ingelheim Group (Germany), CMC Biologics A/S (Denmark), EMD Millipore (U.S.), ProBioGen AG (Germany), Sony Biotechnology Inc. (U.S.), Beckman Coulter (U.S.), Catalent Inc. (U.S.), Lonza Group Ltd. (Switzerland), and Partec (Sysmex Corporation, Japan). With many new biotherapeutics cell line development methods being introduced by leading players, the global market is expected to be highly competitive in the years to come.
By CLD option, the global biotherapeutics cell line development market is classified into in-house, outsource, do-it-yourself (DIY), and hybrid.
Key Segments of Global Biotherapeutics Cell Line Development Market
Global Biotherapeutics Cell Line Development Market, by Process
- Transfection & Selection
- Single Cell Cloning
- Manual limited dilution cloning
Global Biotherapeutics Cell Line Development Market, by CLD Option
- Do-It-Yourself (DIY)
Global Medical Cameras and Microscopes Market, by Geography
- North America
- Asia Pacific (APAC)
- Latin America (LATAM)
- Middle East & Africa
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC